Incretin-Based Therapy Reduces Post-Bariatric Alcohol Use Disorder Risk: JAMA
USA: Recent research suggests that incretin-based weight-loss therapies may offer important neurobehavioral benefits for patients who have undergone bariatric surgery, potentially reducing the risk of alcohol use disorder (AUD). In…